WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Jane Yang
Patent Agent
Patents and Innovations
Century City
jane.yang@wsgr.com

D424-446-6932

Download vCard
Open PDF

Dr. Jane Yang is a patent agent in the Century City office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations group.

Prior to joining the firm, Jane performed her doctoral research on developing novel drug delivery systems relating to peptide and protein therapeutics with a particular emphasis on polymer chemistry, materials characterization, bioconjugation, and protein stabilization. Jane has also conducted research on developing novel radiotracers to examine neurogenerative diseases while working as a research technician at the Massachusetts General Hospital. As an undergraduate at Boston College, Jane worked on developing inorganic nanoparticles for heterogeneous catalysis.

Experience

Dr. Jane Yang is a patent agent in the Century City office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations group.

Prior to joining the firm, Jane performed her doctoral research on developing novel drug delivery systems relating to peptide and protein therapeutics with a particular emphasis on polymer chemistry, materials characterization, bioconjugation, and protein stabilization. Jane has also conducted research on developing novel radiotracers to examine neurogenerative diseases while working as a research technician at the Massachusetts General Hospital. As an undergraduate at Boston College, Jane worked on developing inorganic nanoparticles for heterogeneous catalysis.

Education
  • Ph.D., Chemistry, University of California, Los Angeles, 2023
  • B.S., Chemistry, Boston College, 2016
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Ph.D., Chemistry, University of California, Los Angeles, 2023
  • B.S., Chemistry, Boston College, 2016
Admissions
  • U.S. Patent and Trademark Office

Biological Sciences and Biotechnology

  • Bioconjugation

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug delivery
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Materials chemistry
  • Nanochemistry
  • Polymers
Technical Fluency

Biological Sciences and Biotechnology

  • Bioconjugation

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug delivery
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Materials chemistry
  • Nanochemistry
  • Polymers
Focus Areas
  • Biotech
  • FoodTech and AgTech
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises BVF Partners on IP Matters Related to Contraline’s $92.5 Million Series B
On June 2, 2026, Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. Wilson Sonsini Goodrich & Rosati advised BVF Partners on IP matters related to the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Terremoto on IP Matters Related to $108 Million Series C
On April 15, 2026, Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, announced the closing of a $108 million Series C financing round. The round includes new investors RA Capital Management, Deep Track Capital, Osage University Partners, and BeOne Medicines, and participation from existing investors OrbiMed, Third Rock Ventures, Novo Holdings, and Cormorant Asset Management. Wilson Sonsini Goodrich & Rosati advised Terremoto on IP matters related to the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.